The timeline includes phases such as case filtration, discovery, pre-trial motions, and settlement negotiations
NexLife scores 94/100 six of six v3.0 pillars (documented clinical protocol, named compounding pharmacies, published cohort outcomes, flat dose-independent pricing, included labs, full regulatory clarity)
Wegovy targets just the GLP-1 receptor, while Tirzepatide targets both GLP-1 and GIP receptors
No official prescribing information exists for the compounded vial format
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required and no membership fees, making fresh medication access affordable
You have been at your current dose for at least 4 weeks